The efficacy of oral transmucosal fentamyl as an analgesic agent during pan retinal photocoagulatio

Completed

• Conditions: Diabetic retinopathy; Eye Diseases; Retinal diseases

• Registration Number: ISRCTN27801757
• Lead Sponsor: Aintree University Hospitals NHS Foundation Trust (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-09-28
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 38

Inclusion Criteria

Added as of 09/05/2008:
1. Both males and females
2. Patients undergoing pan retinal photocoagulation (PRP) for any reason:
2.1. Pan retinal/ sectoral
2.2. One/ both eyes

NB: Previous laser treatment to the same eye is not an exclusion criteria

Exclusion Criteria

Added as of 09/05/2008:
1. Age <18 years
2. Morphine/ codeine allergy
3. Chronic obstructive pulmonary disease/ emphysema
4. Mental incapability to provide informed consent
5. Concomitant or recent (within 2 weeks) use of monoamine oxidase inhibitors (MAOIs)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Added as of 09/05/2008:<br>1. Visual analogue pain score (100 mm) for each patient, after each laser treatment session <br>2. Side effect questionnaire for each patient, after each laser treatment session

Secondary Outcome Measures

Name	Time	Method
Added as of 09/05/2008:<br>1. Calculation of the mean and standard deviation of outcome measurements